See how Nexus Copy Number has been used at North Carolina State University to detect copy number changes by CGH analysis in Canines.
A genomics services provider for clinical trials, testing, and research will now be working with BioDiscovery in a co-marketing partnership.
BioDiscovery awarded grant to make further discoveries into tumorigenesis and disease progression and provide a validation set for studies.
Nexus Copy Number for Affymetrix is for data generated by Affymetrix’ genetic analysis platforms in cancer research. Learn more!
Cancer Genetics, Inc. and BioDiscovery announces expansion of the Nexus Copy Number Discovery platform to better predict cancer outcomes.
Biodiscovery, Inc and N-of-One partners to deliver an integrated platform for labs and oncologists to identify targeted therapeutic options.